Pharmacology and Toxicology of Lithium

  • M. Schou
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 55 / 1)

Abstract

Lithium is distinguished by its therapeutic action in mania and its prophylactic action in recurrent manic-depressive disorder of the bipolar and unipolar type. By prophylactic action is meant the ability to attenuate or prevent manic and depressive recurrences. Lithium has a relatively low therapeutic index, and knowledge of its pharmacology and toxicology is important for safe and effective usage.

Keywords

Fatigue Morphine Glucocorticoid Neurol Psoriasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amdisen, A.: Sustained release preparations of lithium. In: Lithium Research and Therapy. Johnson, F.N. (ed). London, New York, San Francisco: Academic Press 1975Google Scholar
  2. Amdisen, A., Schou, M.: Lithium. Side effects of Drugs Annual 2, 17–29 (1978)CrossRefGoogle Scholar
  3. Baastrup, P.C., Hollnagel, P., Sørensen, R., Schou, M.: Adverse reactions in treatment with lithium carbonate and haloperidol. J. Am. Med. Assoc. 236, 2645–2646 (1976)CrossRefGoogle Scholar
  4. Bafaqeeh, H.H., Myers, D.H.: Lithium and thyrotoxicosis. Lancet I, 1409 (1976)CrossRefGoogle Scholar
  5. Berens, S.C., Wolff, J.: The endocrine effects of lithium. In: Lithium Research and Therapy. Johnson, F.N. (ed.). London, New York, San Francisco: Academic Press 1975Google Scholar
  6. Borden, H., Clarke, M.T., Katz, M.: The use of pancuronium bromide in patients receiving lithium carbonate. Can. Anaesth. Soc. J. 21, 79–82 (1974)PubMedCrossRefGoogle Scholar
  7. Brownlie, B.E.W., Chambers, S.T., Sadler, W.A., Donald, R.A.: Lithium associated thyroid disease — a report of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust. N.Z.J. Med. 6, 223–229 (1976)PubMedCrossRefGoogle Scholar
  8. Chaudhri, M.A., Bebbington, P.E.: Lithium therapy and ophthalmic Graves’ disease. Br. J. Psychiatr. 130, 420 (1977)CrossRefGoogle Scholar
  9. Cohen, W.J., Cohen, N.H.: Lithium carbonate, haloperidol, and irreversible brain damage. J. Am. Med. Assoc. 230, 1283–1297 (1974)CrossRefGoogle Scholar
  10. Corrodi, H., Fuxe, K., Hökfelt, T., Schou, M.: The effect of lithium on cerebral monoamine neurons. Psychopharmacology 11, 345–353 (1967)CrossRefGoogle Scholar
  11. Corrodi, H., Fuxe, K., Hökfelt, T., Schou, M.: The effect of prolonged lithium administration on cerebral monoamine neurons in the rat. Life Sci. 8, 643–652 (1969)PubMedCrossRefGoogle Scholar
  12. Cubitt, T.: Lithium and thyrotoxicosis. Lancet I, 1247–1248 (1976)CrossRefGoogle Scholar
  13. Degkwitz, R., Consbruch, U., Haddenbrock, S., Neusch, B., Oehlert, W., Unsöld, T.: Therapeutische Risiken bei der Langzeitbehandlung mit Neuroleptika und Lithium. Klinische, histol ogische und biochemische Befunde. Nervenarzt 47, 81–87 (1976)PubMedGoogle Scholar
  14. Gabriel, E., Karobath, M., Lenz, G.: Extrapyramidale Symptomatik bei Kombination der Lithiumlangzeittherapie mit Nortriptylin. Ein kasuistischer Beitrag zur Pathogenese-Hypo-thesenbildung. Nervenarzt 47, 46–48 (1976)PubMedGoogle Scholar
  15. Genefke, I.K.: The concentration of 5-hydroxytryptamine (5-HT) in hypothalamus, grey and white brain substance in the rat after prolonged oral lithium administration. Acta Psychiatr. Scand. 48, 400–404 (1972)Google Scholar
  16. Gershon, S., Shopsin, B.: Lithium. Its Role in Psychiatric Research and Treatment. New York, London: Plenum 1973Google Scholar
  17. Granacher, R.P.: Neuromuscular problems associated with lithium. Am. J. Psychiatr. 134, 702 (1977)PubMedGoogle Scholar
  18. Grof, P., MacCrimmon, D., Saxena, B., Daigle, L., Prior, M.: Bioavailability and side effects of different lithium carbonate products. Neuropsychobiol. 2, 313–323 (1976)CrossRefGoogle Scholar
  19. Hansen, H.E., Amdisen, A.: Acute renal insufficiency in lithium intoxication. Abs. 12 th Congr. Eur. Dialysis Transplant Assoc. 223 (1975)Google Scholar
  20. Hansen, H.E., Hestbech, J., Amdisen, A., Olsen, S.: Lithium induced nephrogenic diabetes insipidus associated with chronic renal disease. Abs. 13 th Congr. Eur. Dialysis Transplant Assoc. 304 (1976)Google Scholar
  21. Hartitzsch, B. von, Hoenich, N.A., Leigh, R.J., Wilkinson, R., Frost, T.H., Weddel, A., Posen, G.A.: Permanent neurological sequelae despite haemodialysis for lithium intoxication. Br. Med. J. 4, 757–759 (1972)CrossRefGoogle Scholar
  22. Hestbech, J., Hansen, H.E., Amdisen, A., Olsen, S.: Renal lesions following long-term treatment with lithium salts. Kidney Int. 12, 205–213 (1977)PubMedCrossRefGoogle Scholar
  23. Hill, G.E., Wong, K.C., Hodges, M.R.: Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 44, 439–442 (1976)PubMedCrossRefGoogle Scholar
  24. Hill, G.E., Wong, K.C., Hodges, M.R.: Lithium carbonate and neuromuscular blocking agents. Anesthesiology 46, 122–126 (1977)PubMedCrossRefGoogle Scholar
  25. Jefferson, J.W., Greist, J.H.: Primer of Lithium Therapy. Baltimore: Williams & Wilkins 1977Google Scholar
  26. Johnson, F.N. (ed.): Lithium Research and Therapy, London, New York, San Francisco: Academic Press 1975Google Scholar
  27. Juhl, R.P., Tsuang, M.T., Perry, P.J.: Concomitant administration of haloperidol and lithium carbonate in acute mania. Dis. Nerv. Syst. 38, 675–680 (1977)PubMedGoogle Scholar
  28. Juul-Jensen, P., Schou, M.: Permanent brain damage after lithium intoxication. Br. Med. J. 4, 673 (1973)PubMedCrossRefGoogle Scholar
  29. Loudon, J.B., Waring, H.: Toxic reactions to lithium and haloperidol. Lancet II, 1088 (1976)CrossRefGoogle Scholar
  30. Marhold, J., Zimanová, J., Lachman, M., Král, J., Vojtechovský, M.: To the incompatibility of haloperidol with lithium salts. Act. Nerv. Sup. (Praha) 16, 199–200 (1974)Google Scholar
  31. Müller, D., Krüger, E.: Nebenwirkungen der Lithiumtherapie. Psychiatr. Neurol. Med. Psychol. 27, 172–180 (1975)Google Scholar
  32. Neil, J.F., Himmelhoch, J.M., Licata, S.L.: Emergence of myasthenia gravis during treatment with lithium carbonate. Arch. Gen. Psychiatr. 33, 1090–1092 (1976)PubMedGoogle Scholar
  33. Olesen, O.V., Thomsen, K.: Effect of prolonged lithium ingestion on glucagon and parathyroid hormone responses in rats. Acta Pharmacol. Toxicol. (Kbh.) 34, 225–231 (1974)CrossRefGoogle Scholar
  34. Olesen, O.V., Thomsen, K.: A preventive effect of potassium against fatal lithium intoxication in rats. Neuropsychobiol. 2, 112–117 (1976)CrossRefGoogle Scholar
  35. Olesen, O.V., Jensen, J., Thomsen, K.: Effect of potassium on lithium-induced growth retardation and polyuria in rats. Acta Pharmacol. Toxicol. (Kbh.) 36, 161–171 (1975)CrossRefGoogle Scholar
  36. Olesen, O.V., Schou, M., Thomsen, K.: Administration of lithium to rats by different routes. Neuropsychobiol. 2, 134–138 (1976)CrossRefGoogle Scholar
  37. Pedersen, R.S., Svendsen, O.: Lithiumforgiftning behandlet med hæmodialyse. Ugeskr. Læg. 138, 3325–3327 (1976)PubMedGoogle Scholar
  38. Persson, G.: Lithium side effects in relation to dose and to levels and gradients of lithium in plasma. Acta Psychiatr. Scand. 55, 208–213 (1977)PubMedCrossRefGoogle Scholar
  39. Petersen, V., Hvidt, S., Thomsen, K., Schou, M.: The effect of prolonged thiazide treatment on the renal lithium clearance of humans. Br. Med. J. 3, 143–145 (1974)PubMedCrossRefGoogle Scholar
  40. Plenge, P., Mellerup, E.T., Rafaelsen, O.J.: Lithium action on glycogen synthesis in rat brain, liver and diaphragm. J. Psychiatr. Res. 8, 29–36 (1970)PubMedCrossRefGoogle Scholar
  41. Reimherr, F.W., Hodges, M.R., Hill, G.E., Wong, K.C.: Prolongation of muscle relaxant effects by lithium carbonate. Am. J. Psychiatr. 134, 205–206 (1977)PubMedGoogle Scholar
  42. Schou, M.: The biology and pharmacology of lithium: A bibliography. Psychopharmacol. Bull. 5, No. 4, 33–62 (1969)Google Scholar
  43. Schou, M.: A bibliography on the biology and pharmacology of lithium — Appendix I. Psychopharmacol. Bull. 8, No. 4, 36–62 (1972)Google Scholar
  44. Schou, M.: A bibliography on the biology and pharmacology of lithium — Appendix II. Psychopharmacol. Bull. 12, No. 1, 49–74, No. 2, 69–83, No. 3, 86–89 (1976 a)Google Scholar
  45. Schou, M.: Bibliography on the biology and pharmacology of lithium. 4. Neuropsychobiol. 2, 161–191 (1976b)CrossRefGoogle Scholar
  46. Schou, M.: Advances in lithium therapy. Curr. Psychiatr. Ther. 16, 139–162 (1976c)PubMedGoogle Scholar
  47. Schou, M.: Pharmacology and toxicology of lithium. Ann. Rev. Pharmacol. 16, 231–243 (1976d)CrossRefGoogle Scholar
  48. Schou, M.: What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr. Scand. 54, 193–197 (1976 e)PubMedCrossRefGoogle Scholar
  49. Schou, M.: Bibliography on the biology and pharmacology of lithium. 5. Neuropsychobiol. 4, 40–64 (1977)CrossRefGoogle Scholar
  50. Schou, M., Amdisen, A.: Lithium and pregnancy — III, Lithium ingestion by children breast-fed by women in lithium treatment. Br. Med. J. 2, 138 (1973)PubMedCrossRefGoogle Scholar
  51. Schou, M., Amdisen, A., Trap-Jensen, J.: Lithium poisoning. Am. J. Psychiatr. 125, 520–527 (1968)PubMedGoogle Scholar
  52. Schou, M., Baastrup, P.C.: Personal and social implications of lithium maintenance treatment. In: Psychopharmacology, Sexual Disorders and Drug Abuse, Ban, T.A., Boissier, I.R., Gessa, G.J., Heimann, H., Hollister, L., Lehmann, H.E., Munkvad, I., Steinberg, H., Sulser, F., Sundwall, A., Vinaf, O. (eds.), pp. 65–68. Amsterdam, London: North-Holland 1973 Prague: Avicenum 1973Google Scholar
  53. Schou, M., Weinstein, M.R.: Problems of lithium maintenance treatment during pregnancy, delivery and lactation. Agressologie (in press).Google Scholar
  54. Simon, N.M., Garber, E., Arieff, A.J.: Persistent nephrogenic diabetes insipidus after lithium carbonate. Ann. Intern. Med. 86, 446–447 (1977)Google Scholar
  55. Sørensen, R., Jensen, J., Mulder, J., Schou, M.: Lithium side effects and their treatment. Polyuria/polydipsia. Acta Psychiatr. Scand., Suppl. 243, 39 (1973)CrossRefGoogle Scholar
  56. Spaulding, S.W., Burrow, G.N., Ramey, J.N., Donabedian, R.K.: Effect of increased iodide intake on thyroid function in subjects on chronic lithium therapy. Acta Endocrinol. 84, 290–296 (1977)PubMedGoogle Scholar
  57. Sykes, P.A., Quarrie, J., Alexander, F.W.: Lithium carbonate and breast-feeding. Br. Med. J. 4, 1299 (1976)CrossRefGoogle Scholar
  58. Thomsen, K.: Lithium-induced polyuria in rats. Int. Pharmacopsychiatr. 5, 233–241 (1970)Google Scholar
  59. Thomsen, K.: The effect of sodium chloride on kidney function in rats with lithium intoxication. Acta Pharmacol. Toxicol. (Kbh.) 33, 92–102 (1973)Google Scholar
  60. Thomsen, K.: Renal elimination of lithium in rats with lithium intoxication. J . Pharmacol. Exp. Ther. 199, 483 489 (1976)Google Scholar
  61. Thomsen, K., Olesen, O.V.: Long-term lithium administration to rats. Lithium and sodium dosage and administration, avoidance of intoxication, polyuric control rats. Int. Pharma-copsychiatr. 9, 118–124 (1974)Google Scholar
  62. Thomsen, K., Olesen, O.V.: Precipitating factors and renal mechanisms in lithium intoxication. Gen. Pharmacol. 9, 85–89 (1978)Google Scholar
  63. Thomsen, K., Schou, M.: Renal lithium excretion in man. Am. J. Physiol. 215, 823–827 (1968)PubMedGoogle Scholar
  64. Thomsen, K., Schou, M.: The effect of prolonged administration of hydrochlorothiazide on the renal lithium clearance and the urine flow of ordinary rats and rats with diabetes insipidus. Pharmakopsychiatr. 6, 264–269 (1973)CrossRefGoogle Scholar
  65. Thomsen, K., Jensen, J., Olesen, O.V.: Lithium-induced loss of body sodium and the development of severe intoxication in rats. Acta Pharmacol. Toxicol. (Kbh.) 35, 337–346 (1974)CrossRefGoogle Scholar
  66. Thomsen, K., Jensen, J., Olesen, O.V.: Effect of prolonged lithium ingestion on the response to mineralocorticoids in rats. J. Pharmacol. Exp. Ther. 196, 463–468 (1976)PubMedGoogle Scholar
  67. Thornton, W.E., Pray, B.J.: Lithium intoxication: A report of two cases. Can. Psychiatr. Assoc. J. 20, 281–282 (1975)PubMedGoogle Scholar
  68. Tyrer, S., Hullin, R.P., Birch, N.J., Goodwin, J.C.: Absorption of lithium following administration of slow-release and conventional preparations. Psychol. Med. 6, 51–58 (1976)PubMedCrossRefGoogle Scholar
  69. Vendsborg, P.B., Bech, P., Rafaelsen, O.J.: Lithium treatment and weight gain. Acta Psychiatr. Scand. 53, 139–147 (1976)PubMedCrossRefGoogle Scholar
  70. Voetmann, C.: Myastenisk reaktion fremkaldt af lithiumkarbonatbehandling. Ugeskr. Læg. 140, 2375–2376 (1978)Google Scholar
  71. Voorhees, J.J., Marcelo, C.L., Duell, E.A.: Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J. Invest. Dermatol. 65, 179–190 (1975)PubMedCrossRefGoogle Scholar
  72. Widerlöv, E., Sjöström, R., Söderberg, U.: D.D.A.V.P. and lithium-induced polyuria/polydipsia. Lancet II, 1080 (1977)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • M. Schou

There are no affiliations available

Personalised recommendations